Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (NASDAQ: AUVI), founded in 2012, is a pioneering company headquartered in Mount Vernon, New York. The company specializes in the design, manufacture, assembly, and distribution of automated disinfecting mirror systems, primarily for hospitals and healthcare facilities. They also create and supply custom-designed decorative framed mirrors, framed art, and bathroom vanities, catering mainly to the hospitality sector. Applied UV operates extensively across the United States and internationally.
The company's recent achievements include the launch of the Fighter Flex LED solution, which showcases advanced energy efficiency for HVAC systems. This technology, selected by the GSA and DOE for the Green Proving Ground Program, promises substantial energy savings by maintaining HVAC coil efficiency. The patented UVC LED system that Applied UV has developed can reduce energy consumption in HVAC systems by 5-15%, translating to approximately $45,000 in annual savings for a 100,000 square foot office space.
Applied UV is also making significant strides with its Smart Building Technologies division, which is expected to generate substantial revenue. With strategic investments and distribution agreements, the division anticipates a $10 million contribution from just three major accounts in 2024.
Expanding its horizon, Applied UV has engaged in a multi-year exclusive global licensing agreement with Element Designs to enhance outdoor systems for commercial and public spaces. This partnership will incorporate smart building technologies to further reduce energy consumption and enhance visual appeal.
The company’s disinfection technology, particularly the PURONet Control System, integrates continuous and terminal disinfection methods to ensure optimal cleanliness in healthcare settings. This innovative system is especially significant for operating rooms, providing a seamless switch between continuous low-level disinfection and deep terminal cleaning.
Moreover, Applied UV has entered the hospitality market with its plans for Larimar City & Resort in the Dominican Republic, expected to generate $250 million to $300 million over 3-6 years. This multi-use development will benefit from Applied UV’s custom interiors and smart energy-saving solutions.
In March 2024, the company announced a patent application for a disinfection system utilizing multiple wavelengths, enhancing its already robust portfolio of healthcare solutions. This system aims to optimize environmental cleanliness, particularly in healthcare facilities.
Overall, Applied UV continues to drive innovation and develop smart building technologies across healthcare, hospitality, commercial, and municipal markets.
Applied UV has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). The dividend is scheduled for payment on or about August 15, 2022, to holders of record as of August 3, 2022. As a pathogen elimination technology company, Applied UV focuses on infection control across various sectors, utilizing advanced UVC technology for air purification and surface disinfection in healthcare and commercial settings.
Applied UV, Inc. (AUVI) announces the installation of its Airocide™ air purification solution at Advance Beauty College in California. The technology, endorsed by former AACS Board Member Tam Nguyen, targets the beauty salon sector with around 950,000 salons in the U.S. Airocide is recognized as an FDA Class II Medical Device, originally developed for NASA, and offers advanced pathogen elimination. CEO John F. Andrews emphasizes the product’s effectiveness and potential for expanding market reach within the cosmetology field.
Applied UV, Inc. (AUVI) has received a patent from the US Patent and Trademark Office for a system designed to neutralize pathogens on ATM surfaces, enhancing its SteriLumen subsidiary's capabilities. As of 2018, the US had approximately 470,000 ATMs, which pose a risk of pathogen transmission. The CEO emphasized the patent's significance in solidifying Applied UV's market position and expanding potential applications in various sectors. This innovation aims to protect consumers from surface pathogens, thereby reducing litigation risks for banks.
Applied UV, Inc. (NASDAQ: AUVI) has announced a substantial multi-unit follow-on order for its S200 mobile air purification system from MedLine, their exclusive North American distributor. This order aligns with the Centers for Medicare & Medicaid Services (CMS) policy aimed at enhancing air quality in long-term care facilities. The company's air purification sales channel is performing exceptionally well, buoyed by greater awareness of indoor air quality. Should they successfully convert their sales pipeline, significant revenue growth is anticipated in the next 6-12 months.
Applied UV, Inc. (AUVI) announces that its subsidiary SteriLumen has received a significant order for its Airoclean™ 420 air purification technology from Tru Infusion, a major cannabis cultivator in Arizona. This technology, developed for NASA and recognized as an FDA Class II Medical device, enhances air quality across Tru Infusion's 79 facilities, which face challenges due to complex indoor environments. With over 100 units installed, Tru Infusion aims for future purchases as they expand operations. This partnership is expected to strengthen Applied UV's presence in the growing cannabis market.
Applied UV, Inc. (AUVI) has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). This dividend will be payable on or about July 15, 2022, to shareholders on record as of the close of business on July 1, 2022. The company focuses on pathogen elimination technologies that leverage UVC light for surface cleaning and air purification, supporting markets like healthcare and hospitality.
Applied UV, Inc. (AUVI) announces a significant order from its European distributor, Cellarius, to expand the global market share of its Airocide air purification technology, particularly in wineries and food processing. This order underscores Airocide's efficacy in eliminating airborne pathogens, enhancing its appeal to various industries including hospitality and healthcare. Cellarius has been a key partner, recognized as one of Europe’s fastest-growing companies by the Financial Times. CEO John F. Andrews emphasized the importance of this partnership in ensuring safer environments as businesses adapt post-pandemic.
Applied UV, Inc. (AUV) announced the installation of its LumiCide Surface and Drain UVC Disinfecting Systems in 17 patient rooms at Mount Sinai Morningside. This partnership aims to combat hospital-acquired infections, with plans to publish independent validation results from ResInnova Laboratories in an academic paper later this summer. The LumiCide system focuses on pathogen elimination in critical areas, providing automated, continuous disinfection. CEO John F. Andrews stated the collaboration boosts confidence in their innovative solutions within the healthcare sector.
Applied UV, Inc. (AUVI) has expanded its global distribution, partnering with M/S Novatek Pakistan as the sole supplier of Airocide air purification systems for government hospitals in the KPK Province. This agreement follows previous success with the installation of 657 units across the country. Airocide technology, developed for NASA and recognized as an FDA Class II Medical device, aims to enhance indoor air quality and protect against airborne pathogens. The partnership highlights a growing demand for effective air purification in post-pandemic environments.
Applied UV, Inc. (AUVI) has announced a cash dividend of $0.21875 per share for holders of its 10.5% Series A Cumulative Perpetual Preferred Stock (AUVIP). The dividend will be paid on or about June 15, 2022, to shareholders of record at the close of business on June 3, 2022.
The company's technology focuses on pathogen elimination using UVC light and air purification solutions, aiming to address infection control across various sectors including healthcare and hospitality.
FAQ
What is the current stock price of Applied UV (AUVI)?
What is the market cap of Applied UV (AUVI)?
What does Applied UV, Inc. specialize in?
What is the Fighter Flex LED solution?
Where is Applied UV, Inc. headquartered?
What markets does Applied UV serve?
What recent partnerships has Applied UV entered into?
What is the PURONet Control System?
What is the significance of the Larimar City & Resort project?
How does Applied UV's UVC LED technology benefit HVAC systems?
What recent patent application did Applied UV file?
How is Applied UV contributing to energy efficiency?
